Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico
2024; Elsevier BV; Volume: 24; Linguagem: Inglês
10.1016/s2152-2650(24)00665-7
ISSN2152-2650
AutoresLyam Carlo Chacon-Rangel, Sergio Rodríguez‐Rodríguez, Juan Luis Ontiveros-Austria, Roberta Demichelis‐Gómez, Andrés Gómez‐De León, Anna Cecilia Rodríguez-Zúñiga, Sergio I. Inclán-Alarcón, Veronica Steffania Corral-Herrera, Nidia Zapata-Canto, Elia Apodaca,
Tópico(s)Histone Deacetylase Inhibitors Research
Referência(s)